We keep challenging – for living brilliant future together

Yoshihiro Arai

Solasia was founded to develop innovative drugs specializing in oncology area and bring them into Japan and other Asian countries.
We have four product pipelines with our aspiration to deliver better medicines to the patients. Two products were completed the clinical development, approved by the authorities, and launched as well. One product has been completed the final clinical trial.
Our mission, as our company name standing for, is to be the Sun brightening the future for the patients facing the challenges of cancers.
All of us at Solasia continue to challenge and grow further and strive to introduce, develop and provide better treatment options for patients suffering from cancer.
Your understanding and continuous support to Solasia would be highly appreciated.

Yoshihiro Arai
President and Chief Executive Officer

Yoshihiro Arai

Information for use of our products

The site you are about to access is intended to provide information for medical professionals in Japan. It is designed to allow users to better understand Solasia's products.

I have read and understood above

Page Top